Turning Point Therapeutics Names Heather Adams as Vice President of Human Resources
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the appointment of Heather Adams as vice president of Human Resources, effective today. Ms. Adams has more than 20 years of human resources experience, primarily in the health care industry across multiple biotechnology and medical device companies.
“As we grow the company, Heather will play a key role in our efforts to develop our team and build the capabilities necessary for our future,” said Dr. Athena Countouriotis, president and chief executive officer. “One of the key investments we can make at this stage –with a pipeline of four advancing drug candidates -- is to focus on our team and future employment needs. I look forward to having Heather as our partner on this journey.”
Ms. Adams will be responsible for all aspects of human resource management, including organizational development, talent management, staffing and compensation. She joins the company from Bionano Genomics, a publicly traded genomics analysis company where she served as chief administrative officer, responsible for administrative functions including human resources. She previously served in senior human resources positions for life sciences companies of various sizes, including Illumina, Micrus Endovascular and AngioScore. Early in her career, she was a researcher in the areas of protein chemistry, animal physiology and liver cell discovery, resulting in several publications in scientific journals.
“I look forward to working with Athena and the entire management team to help shape the future of Turning Point Therapeutics,” said Ms. Adams. “We operate in a competitive biotech environment and our goal will be to maintain an advantage through initiatives that help develop our existing employees’ capabilities as well as attract additional talented team members to join the company.”
About Turning Point Therapeutics Inc.
Forward Looking Statements
The New Era of Wireless Access and the Great Disconnect
Privacy for IoT
How to Strategically Leverage New Connectivity Options